No black box warning on record for Raloxifene Hydrochloride

As of the latest FDA labeling reviewed, Raloxifene Hydrochloride (RALOXIFENE HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Raloxifene Hydrochloride medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Venous Thromboembolism : Increased risk of deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis. Discontinue use 72 hours prior to and during prolonged immobilization. (5.1 , 6.1) Death Due to Stroke : Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major co

No black box warning on record for Raloxifene Hydrochloride

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Venous Thromboembolism : Increased risk of deep vein thrombosis, pulmonary embolism, and retinal vein thrombosis. Discontinue use 72 hours prior to and during prolonged immobilization. (5.1 , 6.1) Death Due to Stroke : Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major co

Raloxifene Hydrochloride Black Box Warning

No black box warning on record for Raloxifene Hydrochloride

Other warnings & precautions

Raloxifene Hydrochloride Black Box Warning

No black box warning on record for Raloxifene Hydrochloride

Other warnings & precautions